The collaborative determination to bring this promising new drug, milademetan, to those in need. The idea that this drug can help and improve people’s lives who have limited options. The inclusive culture at Rain that drives the focused determination for success.
Mike Roth has over 30 years of pharmaceutical experience overseeing all aspects of quality assurance and compliance. Prior to joining Rain, Mike was vice president of quality and compliance at Principia Biopharma and Sanofi, following its acquisition, where he managed the quality and compliance group, developed standard operating procedures for commercial activities and supported clinical and non-clinical studies. Before his work at Principia and Sanofi, he held various positions focusing on quality assurance and compliance at 10 other biotech and pharmaceutical companies. In addition, he conducted laboratory research at Collagen Corp, Genentech and Roswell Park Memorial Cancer Institute. Mike graduated with an MS in pharmacology from the State University of New York at Buffalo and received his BA in chemistry from the State University College of Buffalo.